GlassScriptPhysician profile
Kay A Johnson
NPI 1306802111
$183,524.37
in general payments reported to CMS, 2019-2025
13 companies · $55K in 2025
The $55K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $7,241 · 2021: $9,287 · 2022: $11K · 2023: $14K · 2024: $50K · 2025: $55K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $100K · Consulting Fee: $8,955 · Travel and Lodging: $4,994 · Food and Beverage: $4,796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $100,002.50 |
| Consulting Fee | $8,955.00 |
| Travel and Lodging | $4,994.25 |
| Food and Beverage | $4,796.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $176,953.56 | 2019-2025 | Biktarvy, Descovy, Yeztugo |
| Shionogi INC | $4,916.97 | 2024 | |
| Theratechnologies INC. | $750.00 | 2021 | |
| Abbott Laboratories | $480.14 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $196.26 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $42.30 | 2025 | Ozempic, Rybelsus |
| Abbvie INC. | $41.94 | 2021-2022 | |
| Viiv Healthcare Company | $34.98 | 2021-2022 | |
| Dexcom, INC. | $29.58 | 2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Axonics, INC. | $20.71 | 2023 | Axonics |
| Vbi Vaccine (Delaware) INC. | $16.97 | 2022 | |
| Janssen Biotech, INC. | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kay Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.